Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Planned sale President and CSO sold 156,530 shares at an average $32.06 ($5,018,292)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4/A Derivatives Options or other derivatives
  9. 4 Planned sale CEO sold 11,654 shares at an average $29.63 ($345,334)
  10. 4 Planned sale President & CSO sold 3,672 shares at an average $29.73 ($109,164)
  11. 4 Planned sale Chief Legal Officer sold 2,092 shares at an average $29.63 ($61,996)
  12. 4 Planned sale Chief Medical Officer sold 16,099 shares at an average $29.87 ($480,843)
  13. 4 Planned sale Chief Financial Officer sold 4,640 shares at an average $29.74 ($137,978)
  14. 4 Option exercise Chief Legal Officer acquired 8,941 shares (option exercise)
  15. 4 Grant or award President & CSO acquired 20,000 shares (grant or award)
  16. 4 Option exercise CEO acquired 13,850 shares (option exercise)
  17. 4 Grant or award Chief Medical Officer acquired 20,000 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 20,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 7 of 12 · 238 filings